Effect of Afatinib plasma levels and pharmacokinetics-related genetic polymorphisms on the degree of side effects in patients with non-small cell lung cancer

Proceedings for Annual Meeting of The Japanese Pharmacological Society(2018)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要